Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
Public ClinicalTrials.gov record NCT00133224. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized, Open-Label Study of Docetaxel in Combination With CG1940 and CG8711 Versus Docetaxel and Prednisone in Taxane-Naïve Patients With Metastatic Hormone-Refractory Prostate Cancer With Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to compare the duration of survival between patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer versus patients receiving docetaxel and prednisone treatment in patients with prostate cancer who no longer respond to hormone therapy, who have documented metastases with pain. Patients may have had up to one prior non-taxane chemotherapy treatment.
Study identification
- NCT ID
- NCT00133224
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 408 participants
Conditions and interventions
Conditions
Interventions
- Immunotherapy allogeneic GM-CSF secreting cellular vaccine Biological
- Chemotherapy (docetaxel and prednisone) Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2005 (Type not available)
- Primary completion
- Aug 2008 (Actual)
- Completion
- Jun 2009 (Estimated)
- Last update posted
- Sep 23, 2008
2005 – 2009
United States locations
- U.S. sites
- 43
- U.S. states
- 23
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Clinical Research Center | Anchorage | Alaska | 99508 | — |
| St. Edward Mercy Medical Center | Fort Smith | Arkansas | 72917 | — |
| Loma Linda University | Loma Linda | California | 92354 | — |
| Onocology Care Medical Associates | Los Angeles | California | 90057 | — |
| Desert Hematology Oncology Medical Group | Rancho Mirage | California | 92270 | — |
| San Bernardino Urology Associates | San Bernardino | California | 92404 | — |
| Kaiser Permanente Medical Group Dept. of Oncology Research | San Diego | California | 92120 | — |
| Sharp Healthcare | San Diego | California | 92123 | — |
| California Pacific Medical Center | San Francisco | California | 94115 | — |
| UCSF Mt. Zion Cancer Center | San Francisco | California | 94115 | — |
| Cancer Research & Prevention Center | Soquel | California | 95073 | — |
| Cancer Center and Department of Medicine | Aurora | Colorado | 80010 | — |
| Mayo Clinic - Jacksonville | Jacksonville | Florida | 32224 | — |
| Jupiter Hematology & Oncology Associates | Jupiter | Florida | 33458 | — |
| Lakeland Regional Cancer Center | Lakeland | Florida | 33804 | — |
| Hematology Oncology Associates of the Treasure Coast | Port Saint Lucie | Florida | 34952 | — |
| Atlanta VA Medical Center | Atlanta | Georgia | 30033 | — |
| Peachtree Hematology & Oncology Consultants, PC | Atlanta | Georgia | 30309 | — |
| Emory Winship Cancer Institute | Atlanta | Georgia | 30322 | — |
| Medical & Surgical Specialists | Galesburg | Illinois | 61401 | — |
| James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Frederick Memorial Hospital Regional Cancer Therapy Center | Frederick | Maryland | 21701 | — |
| General Clinical Research Center University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Billings Clinic | Billings | Montana | 59101 | — |
| Hematology & Oncology Consultants P.C. | Omaha | Nebraska | 68122 | — |
| Nevada Cancer Institute | Las Vegas | Nevada | 89135 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| New Mexico Oncology | Albuquerque | New Mexico | 87109 | — |
| North Shore Hematology Oncology Associates P.C. | East Setauket | New York | 11733 | — |
| NYU Clinical Cancer Center | New York | New York | 10016 | — |
| Presbyterian Hospital Center for Cancer Research | Charlotte | North Carolina | 28204 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Kaiser Permanente Oncology/Hematology | Portland | Oregon | 97227 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
| Center for Oncology Research & Treatment, PA | Dallas | Texas | 75230 | — |
| Dallas Oncology Consultants | Dallas | Texas | 75237 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75246 | — |
| Mobley Research Center | Houston | Texas | 77024 | — |
| Northwest Cancer Center | Houston | Texas | 77042 | — |
| Urology San Antonio Research, PA | San Antonio | Texas | 78229 | — |
| Seattle Cancer Care Alliance, Univ. of Washington | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00133224, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2008 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00133224 live on ClinicalTrials.gov.